A Comparison of Wegovy and Mounjaro: Dosage and Price Differences

Recently, in the obesity treatment market,

Wegovy, which has been enjoying

explosive popularity,

has been joined by a next-generation treatment,

Mounjaro, now launched in Korea. Many people

are comparing the dosage and price of

Wegovy and Mounjaro,

wondering which medication is cheaper,

why the dosage differences exist between the two,

and whether there are separate conditions for

receiving a prescription.

I’d like to take some time to整理 this for those

who are curious.

Wegovy and Mounjaro price comparison

Since you can choose between Wegovy and Mounjaro,

you may want to compare prices and receive a

prescription for the more affordable obesity treatment.

The medication costs for Wegovy and Mounjaro

also increase as the dosage is raised.

👉 In the case of Mounjaro

440,000 won to 660,000 won

👉 In the case of Wegovy

350,000 won to 550,000 won

Because Wegovy and Mounjaro are used in

4-week cycles, rather than simply comparing prices,

it is necessary to calculate the overall budget by

totaling the period over 3 to 6 months.

Also, since there are differences in price and dosage

between Wegovy and Mounjaro, whichever obesity

treatment you choose, it is important to establish an

accurate plan by considering your individual health

status, budget, lifestyle routine, and comorbidities

so that you can achieve the results you want.

Differences in dosage between Wegovy and Mounjaro

Wegovy starts at 0.25 mg and is gradually increased,

while Mounjaro starts at 2.5 mg and is increased

step by step.

The reason there is more than a 10-fold difference in

dosage is that the mechanisms of action are different,

so they should not be compared by dosage units alone.

Wegovy

uses semaglutide as its active ingredient and

stimulates only the GLP-1 receptor, helping to

suppress appetite and increase satiety, focusing on

reducing food intake.

Mounjaro

is a dual-action agent that simultaneously stimulates

two incretins, GLP-1 and GIP, resulting in a greater

degree of weight loss, and research findings suggest

that it also has superior effects on improving the

body’s metabolism and blood sugar control.

Mounjaro’s dual action makes its effects stronger,

which is why it is set to start at a higher dosage,

while Wegovy is based on a single GLP-1 mechanism,

which is why it starts at a lower dosage.

Comparison of prescription conditions for Wegovy and Mounjaro

The obesity treatment Wegovy is approved for adults

and adolescents aged 12 and older with obesity,

while Mounjaro is approved for adult patients with obesity.

The way adult obesity is defined is by a BMI

(body mass index) of 30 kg/㎡ or higher,

or a BMI of 27 kg/㎡ with comorbidities,

in which case a prescription can be issued.

Additionally, in the case of Wegovy,

if there are obesity-related complications

(such as high blood pressure or dyslipidemia),

a prescription can be issued after a doctor’s examination.

Mounjaro is approved for the treatment of

moderate to severe obstructive sleep apnea (OSA)

in patients with obesity, and can therefore be prescribed.

☑️ BMI calculation

BMI = weight (kg) ÷ height² (㎡)

Example) For 162 cm / 70 kg: 70 ÷ (1.62 × 1.62) = 25.716

Which injection treatment is right for me?

According to clinical results, when maintained for

52 weeks or more at the highest approved dose in

Korea, Wegovy has been reported to achieve an

average weight loss of 15%, while Mounjaro has

been reported to achieve more than 19% weight loss.

For people with a large weight-loss goal, Mounjaro

may therefore be attractive.

If your weight-loss goal is not large and you want to

reduce the financial burden, low-dose Wegovy may

be more favorable.

However, the important thing is to choose a medication

that fits your own health condition and lifestyle.

This is not simply a matter of losing weight; it is a

health-related issue, so experience is important when

prescribing obesity treatments.

Based on many years of experience,

Dr. Jo Jung-hoon, the CEO physician of Bliss Clinic,

provides customized prescriptions for Wegovy,

Mounjaro, and the DT7 program by considering various

factors such as the patient’s weight and medical

conditions through consultation.

Even if you are experiencing a plateau or are a

non-responder with Wegovy or Mounjaro, Bliss Clinic’s

DT7 program may be a new solution, so please feel

free to inquire.